Anti-Synthetase Syndrome clinical trials at UCSF
1 in progress, 0 open to eligible people
Showing trials for
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
Sorry, not currently recruiting here
RESET-Myositis: Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects with Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
San Francisco, California and other locations
Our lead scientists for Anti-Synthetase Syndrome research studies include Susan Kim, MD, MMSc.
Last updated: